Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors

Eckert, Franziska; Zwirner, Kerstin; Boeke, Simon; Thorwarth, Daniela; Zips, Daniel; Huber, Stephan M.

dc.contributor.author	Eckert, Franziska
dc.contributor.author	Zwirner, Kerstin
dc.contributor.author	Böke, Simon
dc.contributor.author	Thorwarth, Daniela
dc.contributor.author	Zips, Daniel
dc.contributor.author	Huber, Stephan M.
dc.date.accessioned	2020-05-19T07:56:13Z
dc.date.available	2020-05-19T07:56:13Z
dc.date.issued	2019
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/100775
dc.language.iso	en	en
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2019.00407
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_02150
utue.personen.roh	Eckert, Franziska
utue.personen.roh	Zwirner, Kerstin
utue.personen.roh	Boeke, Simon
utue.personen.roh	Thorwarth, Daniela
utue.personen.roh	Zips, Daniel
utue.personen.roh	Huber, Stephan M.
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 407	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige